2016
DOI: 10.1097/mph.0000000000000548
|View full text |Cite
|
Sign up to set email alerts
|

Early Posttherapy Hospitalizations Among Survivors of Childhood Leukemia and Lymphoma

Abstract: Long-term survivors of childhood cancers are at increased risk for hospitalization. To test the hypothesis that many treatment-related morbidities are identifiable in the early post-therapy period, we determined the rates and causes for hospitalization among survivors of leukemia and lymphoma during the first three years post-therapy. Using a health plan claims database, we identified patients aged 0-21 years-old treated for leukemia or lymphoma from 2000-2010. Survivors were matched 10:1 with similar children… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
5
0
2

Year Published

2016
2016
2021
2021

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 19 publications
1
5
0
2
Order By: Relevance
“…In addition, recent studies have pointed to the significant impact of enduring compliance to therapy since young patients will require long‐term and molecularly targeted therapy under regular monitoring. Their prognosis also seems to be dismal in case of relapsed or refractory disease, especially for specific subtypes, such as the B‐cell and lymphoblastic NHL . Last, the known poor prognosis of specific NHL subtypes, namely, mature B‐cell and mature T‐cell and NK‐cell lymphomas in younger compared with older children, is also in accordance with previous studies; the cancer registration type of our data entailing a high proportion of NHL NOS cases is to be, however, acknowledged.…”
Section: Discussionsupporting
confidence: 90%
“…In addition, recent studies have pointed to the significant impact of enduring compliance to therapy since young patients will require long‐term and molecularly targeted therapy under regular monitoring. Their prognosis also seems to be dismal in case of relapsed or refractory disease, especially for specific subtypes, such as the B‐cell and lymphoblastic NHL . Last, the known poor prognosis of specific NHL subtypes, namely, mature B‐cell and mature T‐cell and NK‐cell lymphomas in younger compared with older children, is also in accordance with previous studies; the cancer registration type of our data entailing a high proportion of NHL NOS cases is to be, however, acknowledged.…”
Section: Discussionsupporting
confidence: 90%
“…32 In the Childhood Cancer Survivors Study, 5-year cancer survivors self-reported a 30% higher frequency of infections compared with their siblings 33 and were at a 1.6 to 2.7 increased risk of infection-related hospitalizations compared with the general population. 34 Finally, higher rates of infection-related hospitalizations have been reported in retrospective cohort studies, [35][36][37] especially in the initial years post-treatment. In our study, the absence of a difference between groups for 31 : moderately intensive, low-, standard-, or intermediate-risk precursor B-cell ALL; very intensive, high-risk or very-high-risk precursor B-cell ALL, T-cell ALL, AML and Down syndrome or acute promyelocytic leukemia; and most intensive, AML not associated with Down syndrome or any treatment protocol that requires HSCT.…”
Section: Discussionmentioning
confidence: 96%
“…Although the increased association between pediatric cancer and chronic conditions in adulthood has been well studied, the conditions experienced by early survivors–children and adolescents who are only a few years out from the completion of therapy–are unclear . This population has been shown to fill more prescriptions from more drug classes, and to be at an increased risk of having a hospitalization, compared with children who have not experienced cancer . Unfortunately, existing evidence does not consider the variety of combinations of conditions these children might experience, and the way those conditions relate to one another.…”
Section: Introductionmentioning
confidence: 99%